×
Duloxetine in the Treatment of Major Depressive Disorder: Comparisons of Safety and Efficacy in U.S. Hispanic and Majority Caucasian Patients PDF
$ 40.00
Duloxetine in the Treatment of Major Depressive Disorder: Comparisons of Safety and Efficacy in U.S. Hispanic and Majority Caucasian Patients PDF quantity
$ 40.00
×
Health-Related Quality of Life Across the Anxiety Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) PDF
$ 40.00
Health-Related Quality of Life Across the Anxiety Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) PDF quantity
$ 40.00
×
Double-Blind, Placebo-Controlled Study of the Efficacy of Reboxetine and Citalopram as Adjuncts to Atypical Antipsychotics for Negative Symptoms of Schizophrenia PDF
$ 40.00
Double-Blind, Placebo-Controlled Study of the Efficacy of Reboxetine and Citalopram as Adjuncts to Atypical Antipsychotics for Negative Symptoms of Schizophrenia PDF quantity
$ 40.00
×
The Epidemiology of Chronic Major Depressive Disorder and Dysthymic Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions PDF
$ 40.00
The Epidemiology of Chronic Major Depressive Disorder and Dysthymic Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions PDF quantity
$ 40.00
×
Effectiveness of a Brief Behavioral Treatment for Inner-City Illicit Drug Users With Elevated Depressive Symptoms: The Life Enhancement Treatment for Substance Use (LETS Act!) PDF
$ 40.00
Effectiveness of a Brief Behavioral Treatment for Inner-City Illicit Drug Users With Elevated Depressive Symptoms: The Life Enhancement Treatment for Substance Use (LETS Act!) PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart